Physician
Ascension Medical Group Genesys
Ascension Medical Group Genesys was paid $13.06M by Medicaid between Jan 2019 and Dec 2024, across 120 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoASCENSION MEDICAL GROUP GENESYS
MOUNT MORRIS, MI 48458
MOUNT MORRIS, MI 48458
33aNPI1003398470assigned 09/03/2018
33bProvider typeInternal Medicine Physician
28Total paid$13.06M
24GClaims278,674
24DCodes billed120
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Michigan
Rank by total paid#8 of 816
Median peer was paid$70K
This provider vs. median185×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 54,813 | $2.07M | |
| 2020 | 48,293 | $1.91M | |
| 2021 | 49,313 | $2.33M | |
| 2022 | 50,678 | $2.48M | |
| 2023 | 47,091 | $2.60M | |
| 2024incomplete | 28,486 | $1.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 55,196 | 52,449 | $4.45M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 73,720 | 67,487 | $4.15M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.2% | 8,471 | 8,462 | $809K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.5% | 6,829 | 6,819 | $589K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 4,460 | 4,457 | $351K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.6% | 4,764 | 4,711 | $345K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 3,415 | 3,411 | $290K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.2% | 3,697 | 3,696 | $290K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 2,054 | 1,984 | $222K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.5% | 8,465 | 8,415 | $192K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.1% | 4,061 | 881 | $149K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 1,207 | 1,205 | $143K |
108 more codes
| 99496 | <1% | 857 | $102K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,069 | $67K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 829 | $67K |
| 90682 | <1% | 1,388 | $66K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,899 | $65K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,184 | $65K |
| 99443 | <1% | 582 | $49K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,079 | $42K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,306 | $42K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 527 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,014 | $29K |
| 99442 | <1% | 492 | $29K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,090 | $28K |
| 81002 | <1% | 9,687 | $24K | |
| 20610 | <1% | 800 | $21K | |
| 99223 | Prolong inpt eval add15 m | <1% | 187 | $20K |
| 93000 | <1% | 2,583 | $19K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,859 | $18K |
| 90756 | <1% | 808 | $17K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,383 | $16K |
| 90715 | <1% | 778 | $16K | |
| 80305 | <1% | 2,004 | $16K | |
| 99460 | <1% | 285 | $16K | |
| 99188 | <1% | 1,852 | $14K | |
| 90686 | <1% | 2,492 | $13K | |
| 99349 | <1% | 270 | $13K | |
| 83655 | <1% | 1,282 | $13K | |
| 17110 | <1% | 215 | $12K | |
| 99406 | <1% | 1,754 | $12K | |
| 81025 | <1% | 1,722 | $12K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 364 | $11K |
| 99495 | <1% | 93 | $8K | |
| 99441 | <1% | 198 | $8K | |
| 99463 | <1% | 108 | $7K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 69 | $5K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 547 | $5K |
| 99000 | <1% | 379 | $5K | |
| 90651 | <1% | 296 | $4K | |
| 85018 | <1% | 2,217 | $4K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 183 | $4K |
| 90674 | <1% | 197 | $4K | |
| 85014 | <1% | 1,804 | $3K | |
| 81003 | <1% | 2,227 | $3K | |
| 90688 | <1% | 262 | $3K | |
| 99381 | <1% | 39 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 90 | $3K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 439 | $3K |
| 90670 | <1% | 2,203 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,914 | $3K |
| 99348 | <1% | 87 | $2K | |
| 90673 | <1% | 40 | $2K | |
| 82962 | <1% | 1,179 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,778 | $2K |
| D0190 | <1% | 130 | $2K | |
| 90677 | <1% | 414 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 362 | $2K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 122 | $1K |
| 99385 | <1% | 12 | $1K | |
| 94010 | <1% | 75 | $1K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 61 | $1K |
| 90732 | <1% | 12 | $1K | |
| 99407 | <1% | 88 | $1K | |
| 90661 | <1% | 38 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 126 | $942.00 |
| 99220 | <1% | 12 | $928.89 | |
| 87807 | <1% | 86 | $824.60 | |
| 82570 | <1% | 231 | $714.90 | |
| 94060 | <1% | 25 | $690.65 | |
| 90734 | <1% | 250 | $644.25 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 107 | $620.04 |
| 80061 | Lipid panel | <1% | 52 | $545.85 |
| 90716 | <1% | 1,086 | $545.04 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 528 | $466.11 |
| 90707 | <1% | 1,089 | $462.90 | |
| 90662 | <1% | 146 | $345.02 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 87 | $309.33 |
| 90656 | <1% | 44 | $290.55 | |
| 96160 | <1% | 71 | $281.21 | |
| G0008 | Administration of influenza virus vaccine | <1% | 967 | $230.53 |
| 90620 | <1% | 40 | $180.20 | |
| 90619 | <1% | 120 | $156.84 | |
| 85610 | <1% | 54 | $146.88 | |
| 86580 | <1% | 15 | $77.25 | |
| 90685 | <1% | 62 | $41.33 | |
| 82270 | <1% | 12 | $32.58 | |
| 90700 | 0% | 472 | $0.00 | |
| 3045F | 0% | 185 | $0.00 | |
| 90633 | 0% | 1,051 | $0.00 | |
| 90461 | 0% | 371 | $0.00 | |
| 3046F | 0% | 326 | $0.00 | |
| 3051F | 0% | 383 | $0.00 | |
| 1160F | 0% | 17 | $0.00 | |
| 90648 | 0% | 120 | $0.00 | |
| 90713 | 0% | 13 | $0.00 | |
| 90621 | 0% | 25 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 55 | $0.00 |
| 90672 | 0% | 19 | $0.00 | |
| 3078F | 0% | 12 | $0.00 | |
| 98966 | 0% | 13 | $0.00 | |
| 90698 | 0% | 1,986 | $0.00 | |
| 90744 | 0% | 1,382 | $0.00 | |
| 1111F | 0% | 485 | $0.00 | |
| 90680 | 0% | 1,762 | $0.00 | |
| 3044F | 0% | 1,973 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 12 | $0.00 |
| 3052F | 0% | 39 | $0.00 | |
| 3048F | 0% | 29 | $0.00 | |
| 90696 | 0% | 91 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEDGAR, WILLIAM (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Ascension Medical Group Genesys | Burton, MI | $1.77M |
| Ascension Medical Group Genesys | Burton, MI | $1.24M |
| Ascension Medical Group Genesys | Burton, MI | $396K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.